A detailed history of Ea Series Trust transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ea Series Trust holds 694 shares of REGN stock, worth $495,842. This represents 0.02% of its overall portfolio holdings.

Number of Shares
694
Holding current value
$495,842
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$700.03 - $830.35 $485,820 - $576,262
694 New
694 $499 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ea Series Trust Portfolio

Follow Ea Series Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ea Series Trust, based on Form 13F filings with the SEC.

News

Stay updated on Ea Series Trust with notifications on news.